Financed by the European Commission, the European AIDS Vaccine Initiative (EAVI2020) brings together leading HIV researchers from public organisations and biotech companies from across Europe, Australia, Canada and the USA in a focused effort to develop protective and therapeutic HIV vaccines.
HIV scientists launch £17 million project to develop vaccine
General Research
9 November 2015
A new €23 million (£17 million) initiative to accelerate the search for an effective HIV vaccine has begun.
